Company intelligence / Profile preview
iRegene Therapeutics
Wuhan, China
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
iRegene Therapeutics has developed a unique "AI + chemical induction" platform to generate universal allogeneic cell therapies from induced pluripotent stem cells. Its lead product NouvNeu001 has shown significant improvement in motor scores with good safety profile in mid-to-late stage Parkinson’s disease patients during ongoing multicenter clinical studies. The company also received FDA Orphan Drug Designation for its retinal disease program NouvSight001. Clinical trials are underway or planned across multiple neurodegenerative and degenerative conditions.
- Therapeutic areas
- OphthalmologyGastroenterologyCardiovascularNeurology
- Modalities
- Cell therapy (chemically defined/allogeneic)Induced pluripotent stem cells (iPSC)Exosomes
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on iRegene Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on iRegene Therapeutics.